Published HCC genomics cohorts (TCGA, AMC and Inserm) showed corroborating data that ABCB5 mutation rate and copy number variation in HCC was rare event (2.6%, 22/851) (Figure S3), where the ABCB5 expression data were similarly compared to different patient cohorts and cancer types. Here, ABCB5 is linked to cancer.